Johnson & Johnson is recalling all infant Tylenol on the U.S. market because some parents have had problems with newly designed bottles, just introduced three months ago.
It was touted by the company as a big improvement to make measuring the correct dose easier. Some parents complained that a protective cover on the top of the bottles meant to limit how much liquid pain reliever could be
drawn into a plastic syringe didn't work. When consumers inserted the plastic syringe, it pushed the protective cover, or flow restrictor, into the bottle.
J&J's McNeil Consumer Healthcare, plagued by about 25 product recalls since September 2009, says it is recalling all 574,000 bottles of a grape-flavored version of the liquid medicine on the market. The product, which was distributed nationally, was introduced in November.
It's one of the first nonprescription medicines reintroduced after all the recalls and an ongoing factory shutdown have kept most of McNeil's medicines off the market for well over a year, costing the company well over $1 billion in lost revenue, plus many millions for ongoing factory improvements.
